
    
      A Phase 1, Single Centre, Double-blind, Randomised, Placebo-controlled, Study to Investigate
      the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics after Administration of
      Multiple Ascending (MAD) Once Weekly Inhaled Doses of AZD8848 in Healthy Subjects
    
  